ZA200306542B - 1-Aryl-or 1-alkylsulfonylbenzazole derivatives a 5-hydroxy-tryptamine-6 ligands. - Google Patents
1-Aryl-or 1-alkylsulfonylbenzazole derivatives a 5-hydroxy-tryptamine-6 ligands.Info
- Publication number
- ZA200306542B ZA200306542B ZA200306542A ZA200306542A ZA200306542B ZA 200306542 B ZA200306542 B ZA 200306542B ZA 200306542 A ZA200306542 A ZA 200306542A ZA 200306542 A ZA200306542 A ZA 200306542A ZA 200306542 B ZA200306542 B ZA 200306542B
- Authority
- ZA
- South Africa
- Prior art keywords
- tryptamine
- ligands
- aryl
- hydroxy
- alkylsulfonylbenzazole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Addiction (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26342501P | 2001-01-23 | 2001-01-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200306542B true ZA200306542B (en) | 2005-11-21 |
Family
ID=23001722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200306542A ZA200306542B (en) | 2001-01-23 | 2003-08-21 | 1-Aryl-or 1-alkylsulfonylbenzazole derivatives a 5-hydroxy-tryptamine-6 ligands. |
Country Status (23)
| Country | Link |
|---|---|
| US (4) | US6509357B1 (fr) |
| EP (1) | EP1353904B9 (fr) |
| JP (1) | JP4208573B2 (fr) |
| KR (1) | KR20030068591A (fr) |
| CN (1) | CN1273450C (fr) |
| AR (1) | AR034203A1 (fr) |
| AT (1) | ATE312078T1 (fr) |
| AU (1) | AU2002251811B2 (fr) |
| BR (1) | BR0206633A (fr) |
| CA (1) | CA2435566A1 (fr) |
| DE (1) | DE60207815T2 (fr) |
| DK (1) | DK1353904T3 (fr) |
| EA (1) | EA006057B1 (fr) |
| ES (1) | ES2250638T3 (fr) |
| HU (1) | HUP0401009A3 (fr) |
| IL (1) | IL157059A0 (fr) |
| MX (1) | MXPA03006479A (fr) |
| NO (1) | NO20033300L (fr) |
| NZ (1) | NZ527051A (fr) |
| PL (1) | PL364568A1 (fr) |
| TW (1) | TW593278B (fr) |
| WO (1) | WO2002059088A1 (fr) |
| ZA (1) | ZA200306542B (fr) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20030088507A (ko) * | 2001-04-20 | 2003-11-19 | 와이어쓰 | 5-하이드록시트립타민-6 리간드로서의헤테로사이클릴알콕시-, -알킬티오- 및-알킬아미노벤즈아졸 유도체 |
| EP1385842A1 (fr) * | 2001-04-20 | 2004-02-04 | Wyeth | Derives d'heterocyclyloxy-, -thioxy- et aminobenzazol servant de ligands de 5-hydroxytryptamine-6 |
| YU96103A (sh) * | 2001-06-07 | 2006-08-17 | F.Hoffmann-La Roche Ag. | Novi derivati indola sa afinitetom za 5-ht6 receptor |
| WO2003068740A1 (fr) * | 2002-02-14 | 2003-08-21 | Wyeth | Derives de pyrrolylalkylidene-hydrazinecarboxymidamide tels que des ligands 5-hydroxytryptamine-6 |
| WO2003104193A1 (fr) * | 2002-06-05 | 2003-12-18 | F. Hoffmann-La Roche Ag | Derives de 1-sulfonyl-4-aminoalcoxy-indole et leur utilisation comme modulateurs des recepteurs 5-ht6 en traitement de troubles du snc |
| AU2003268117A1 (en) * | 2002-09-18 | 2004-04-08 | Eli Lilly And Company | Histamine h3 receptor antagonists, preparaton and therapeutic uses |
| WO2004050085A1 (fr) * | 2002-12-03 | 2004-06-17 | F. Hoffmann-La Roche Ag | Indols aminoalkoxy utilises en tant que ligands du recepteur 5-ht6 pour le traitement de troubles du snc |
| MXPA05008438A (es) * | 2003-02-14 | 2005-10-19 | Wyeth Corp | Heterociclil-3-sulfonilindazoles como ligandos de 5-hidroxitriptamina-6. |
| US7135575B2 (en) | 2003-03-03 | 2006-11-14 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
| SE0302760D0 (sv) * | 2003-10-20 | 2003-10-20 | Biovitrum Ab | New compounds |
| WO2005085248A1 (fr) | 2004-02-27 | 2005-09-15 | F.Hoffmann-La Roche Ag | Derives pyrazolo heteroaryl-condenses |
| RU2006134022A (ru) | 2004-02-27 | 2008-04-10 | Ф.Хоффманн-Ля Рош Аг (Ch) | Производные индазола и содержащие их фармацевтические композиции |
| RU2006134020A (ru) | 2004-02-27 | 2008-04-10 | Ф.Хоффманн-Ля Рош Аг (Ch) | Конденсированные производные пиразола |
| US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| CA2883044C (fr) * | 2004-10-08 | 2017-08-15 | Sdb Ip Holdings, Llc | Robinet a diaphragme a detecteur de pression electronique |
| CA2586179C (fr) | 2004-11-02 | 2011-02-08 | Pfizer Inc. | Derives de sulfonyl benzimidazole |
| JP5146766B2 (ja) * | 2005-08-15 | 2013-02-20 | ワイス・エルエルシー | ５−ヒドロキシトリプタミン−６リガンドとしての置換−３−スルホニルインダゾール誘導体 |
| MX2008002588A (es) | 2005-08-25 | 2008-03-18 | Hoffmann La Roche | Inhibidores de p38-map-cinasa y los metodos para utilizarlos. |
| TWI387592B (zh) * | 2005-08-30 | 2013-03-01 | Novartis Ag | 經取代之苯并咪唑及其作為與腫瘤形成相關激酶之抑制劑之方法 |
| SG175599A1 (en) | 2006-01-31 | 2011-11-28 | Array Biopharma Inc | Kinase inhibitors and methods of use thereof |
| CN101432274A (zh) * | 2006-04-05 | 2009-05-13 | 惠氏公司 | 作为5-羟色胺-6配体的磺酰基-3-杂环吲唑衍生物 |
| WO2007120596A1 (fr) * | 2006-04-12 | 2007-10-25 | Wyeth | DÉRIVÉS DE DIHYDRO[1,4]DIOXINO[2,3-e]INDAZOLE EN TANT QUE LIGANDS DE 5-HYDROXYTRYPTAMINE-6 |
| CN101432269A (zh) * | 2006-06-01 | 2009-05-13 | 惠氏公司 | 作为5-羟色胺-6配体的1-磺酰基吲唑基胺和1-磺酰基吲唑基酰胺衍生物 |
| US20090023925A1 (en) * | 2007-06-28 | 2009-01-22 | Wyeth | N'-(2-halobenzylidene)sulfonylhydrazides as intermediates in the manufacture of arylsulfonylindazoles |
| ES2616238T3 (es) | 2010-10-06 | 2017-06-12 | Glaxosmithkline Llc, Corporation Service Company | Derivados de bencimidazol como inhibidores de PI3 quinasa |
| US9663498B2 (en) | 2013-12-20 | 2017-05-30 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic compounds and their application in pharmaceuticals |
| US9974785B2 (en) | 2014-07-08 | 2018-05-22 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic derivatives and pharmaceutical applications thereof |
| CA3037587A1 (fr) | 2016-09-30 | 2018-04-05 | Epizyme, Inc. | Composes bi-ou tri-heterocycliques fusionnes substitues en tant qu'inhibiteurs de l'ehmt2 |
| US11672800B2 (en) | 2017-04-21 | 2023-06-13 | Epizyme, Inc. | Combination therapies with EHMT2 inhibitors |
| AU2018360766A1 (en) | 2017-11-06 | 2020-05-21 | Rapt Therapeutics, Inc. | Anticancer agents |
| CN112847099A (zh) * | 2021-03-08 | 2021-05-28 | 王佳丽 | 一种有效调节进给量实现自动切割的砂轮切割机 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2905877A1 (de) * | 1979-02-16 | 1980-08-28 | Boehringer Mannheim Gmbh | Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| EP0736023B1 (fr) * | 1993-12-21 | 1998-07-08 | Smithkline Beecham Plc | Derives indole, indoline et quinoleine possedant une activite antagoniste (anti-depressive) du 5ht 1d |
| GB9416972D0 (en) | 1994-08-23 | 1994-10-12 | Smithkline Beecham Plc | Carbon side chain/indole/indolene |
| JP2000501107A (ja) * | 1996-01-09 | 2000-02-02 | イーライ・リリー・アンド・カンパニー | ベンズイミダゾリル神経ペプチドｙ受容体アンタゴニスト |
| GB9600344D0 (en) | 1996-01-09 | 1996-03-13 | Lilly Co Eli | Benzimidzolyl neuropeptide y receptor antagonists |
| WO1997031635A1 (fr) * | 1996-03-01 | 1997-09-04 | Eli Lilly And Company | Procedes de traitement ou de prevention de l'apnee du sommeil |
| AU5343298A (en) | 1997-01-13 | 1998-08-03 | Yamanouchi Pharmaceutical Co., Ltd. | 5-ht2c receptor agonists and aminoalkylindazole derivatives |
| US5872144A (en) | 1997-02-18 | 1999-02-16 | American Home Products Corporation | 4-aminoethoxyindazole derivatives |
| US6127380A (en) | 1997-02-18 | 2000-10-03 | American Home Products Corporation | 4-aminoalkoxy-1H-benzoimidazoles |
| EP1068224B1 (fr) | 1998-03-31 | 2005-05-11 | Bristol-Myers Squibb Pharma Company | Produits pharmaceutiques pour l'imagerie de troubles angiogenes |
| GB9820113D0 (en) * | 1998-09-15 | 1998-11-11 | Merck Sharp & Dohme | Therapeutic agents |
| PT1140203E (pt) * | 1998-12-18 | 2007-08-30 | Bristol Myers Squibb Pharma Co | Medicamentos antagonistas do receptor da vitronectina |
| GB9902452D0 (en) * | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
| GB0019950D0 (en) * | 2000-08-12 | 2000-09-27 | Smithkline Beecham Plc | Compounds |
-
2001
- 2001-12-26 TW TW090132299A patent/TW593278B/zh not_active IP Right Cessation
-
2002
- 2002-01-18 DE DE60207815T patent/DE60207815T2/de not_active Expired - Lifetime
- 2002-01-18 AT AT02720837T patent/ATE312078T1/de not_active IP Right Cessation
- 2002-01-18 EA EA200300829A patent/EA006057B1/ru not_active IP Right Cessation
- 2002-01-18 KR KR10-2003-7009699A patent/KR20030068591A/ko not_active Application Discontinuation
- 2002-01-18 JP JP2002559390A patent/JP4208573B2/ja not_active Expired - Fee Related
- 2002-01-18 CA CA002435566A patent/CA2435566A1/fr not_active Abandoned
- 2002-01-18 CN CNB028067576A patent/CN1273450C/zh not_active Expired - Fee Related
- 2002-01-18 EP EP02720837A patent/EP1353904B9/fr not_active Expired - Lifetime
- 2002-01-18 DK DK02720837T patent/DK1353904T3/da active
- 2002-01-18 AU AU2002251811A patent/AU2002251811B2/en not_active Ceased
- 2002-01-18 PL PL02364568A patent/PL364568A1/xx not_active Application Discontinuation
- 2002-01-18 NZ NZ527051A patent/NZ527051A/en unknown
- 2002-01-18 WO PCT/US2002/001950 patent/WO2002059088A1/fr active IP Right Grant
- 2002-01-18 IL IL15705902A patent/IL157059A0/xx unknown
- 2002-01-18 HU HU0401009A patent/HUP0401009A3/hu unknown
- 2002-01-18 MX MXPA03006479A patent/MXPA03006479A/es active IP Right Grant
- 2002-01-18 BR BR0206633-5A patent/BR0206633A/pt not_active IP Right Cessation
- 2002-01-18 ES ES02720837T patent/ES2250638T3/es not_active Expired - Lifetime
- 2002-01-22 AR ARP020100210A patent/AR034203A1/es not_active Application Discontinuation
- 2002-01-22 US US10/055,365 patent/US6509357B1/en not_active Expired - Fee Related
- 2002-12-09 US US10/314,726 patent/US6710069B2/en not_active Expired - Fee Related
-
2003
- 2003-07-22 NO NO20033300A patent/NO20033300L/no not_active Application Discontinuation
- 2003-08-21 ZA ZA200306542A patent/ZA200306542B/xx unknown
- 2003-10-28 US US10/695,490 patent/US20040092564A1/en not_active Abandoned
- 2003-10-29 US US10/696,433 patent/US6919354B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200306542B (en) | 1-Aryl-or 1-alkylsulfonylbenzazole derivatives a 5-hydroxy-tryptamine-6 ligands. | |
| IL162242A0 (en) | Azaindolylalkylamine derivatives as5-hydroxytryptamine-6 ligands | |
| HK1061621A1 (en) | A fencing. | |
| MXPA03008140A (es) | Amidas de acido benzofuran-2-carboxilico sustituidas. | |
| GB0012054D0 (en) | Ligands | |
| AU149656S (en) | A cart-housing | |
| MXPA03008394A (es) | Derivados de biuretano. | |
| ZA200404185B (en) | A sawmill. | |
| HK1059781A1 (en) | New phenylpiperazines. | |
| GB0115841D0 (en) | Ligand | |
| ZA200203813B (en) | A tomb. | |
| GB2372253B (en) | A render | |
| GB0121122D0 (en) | D.a.r.t | |
| ZA200204263B (en) | A bed. | |
| ZA200205529B (en) | A conveyor. | |
| ZA200203337B (en) | A cooking bag. | |
| ZA200208989B (en) | A cooker. | |
| ZA200200034B (en) | A food substance. | |
| ZA200002483B (en) | A wind-dryer. | |
| ZA200201235B (en) | A study aid. | |
| GB0024022D0 (en) | S.A.R.E. Energynet | |
| ZA200205431B (en) | A medicament. | |
| ZA200300453B (en) | A belt. | |
| AU147444S (en) | A T-shirt | |
| AU147226S (en) | A T-shirt |